Contrast induced nephropathy natural history, complications and prognosis

Revision as of 18:07, 11 September 2013 by Mohamed Moubarak (talk | contribs)
Jump to navigation Jump to search

Contrast Induced Nephropathy Microchapters

Home

Patient Information

Overview

Definition

Historical Perspective

Pathophysiology

Differentiating Contrast induced nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Contrast induced nephropathy natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Contrast induced nephropathy natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Contrast induced nephropathy natural history, complications and prognosis

CDC on Contrast induced nephropathy natural history, complications and prognosis

Contrast induced nephropathy natural history, complications and prognosis in the news

Blogs on Contrast induced nephropathy natural history, complications and prognosis

Directions to Hospitals Treating Contrast induced nephropathy

Risk calculators and risk factors for Contrast induced nephropathy natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

Overview

The reported incidence of CIN varies widely depending on the presence or absence of risk factors, CIN associated with a significantly higher risk of in-hospital and 1-year mortality, even in patients who do not need dialysis.

Natural history, Complications and Prognosis

There is a complicated relationship between CIN, comorbidity, and mortality. Most patients who develop CIN do not die from renal failure rather than from either a preexisting nonrenal complication, or a procedural complication.

Nonrenal complications include procedural cardiac complications (eg, Q-wave MI, coronary artery bypass graft [CABG], hypotension, shock), vascular complications (eg, femoral bleeding, hematoma, pseudoaneurysm, stroke), and systemic complications (eg, acute respiratory distress syndrome [ARDS], pulmonary embolism).

References

Template:WH Template:WS